Work

DRAK2 is a promising target to inhibit GvHD without negatively impacting graft reconstitution after bone marrow transplant

Year: 2022

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.208.supp.175.05

Authors: Marygrace S Duggar, Marie Wehenkel, Peter Vogel, Maureen Ann McGargill

Institution: St. Jude Children's Research Hospital

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313408097

Cites:

Cited by:

Related to: 10